Percutaneous Irreversible Electroportion for Unresectable Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

December 1, 2020

Study Completion Date

January 1, 2021

Conditions
Breast Cancer
Interventions
DEVICE

NanoKnife LEDC System

Irreversible electroporation (IRE) is a method to induce irreversible disruption of cell membrane integrity (loss of cell homeostasis) resulting in cell death without the need for additional pharmacological injury. Because IRE is a non-thermal technique, changes associated with perfusion-mediated tissue cooling (or heating) are not relevant. While cells in the ablation region are destroyed, the underlying extracellular matrix is not damaged thus allowing tissues in the ablation zone to heal normally.

Trial Locations (1)

510665

FUDA Cancer Hospital, Guangzhou

All Listed Sponsors
lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT02340858 - Percutaneous Irreversible Electroportion for Unresectable Breast Cancer | Biotech Hunter | Biotech Hunter